Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Drop in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 4,300 shares, a decline of 18.9% from the March 31st total of 5,300 shares. Based on an average daily trading volume, of 57,600 shares, the short-interest ratio is presently 0.1 days.

Ocean Biomedical Stock Down 28.8 %

Shares of NASDAQ OCEAW traded down $0.03 during trading on Friday, hitting $0.08. 4,150 shares of the company traded hands, compared to its average volume of 53,490. The company has a 50-day moving average price of $0.22 and a 200-day moving average price of $0.11. Ocean Biomedical has a 1 year low of $0.02 and a 1 year high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.